M
Masashi Mizokami
Researcher at Nagoya City University
Publications - 684
Citations - 37168
Masashi Mizokami is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Hepatitis C virus. The author has an hindex of 85, co-authored 650 publications receiving 34868 citations. Previous affiliations of Masashi Mizokami include National Institute of Advanced Industrial Science and Technology & University of Florida.
Papers
More filters
Journal ArticleDOI
Genotype, serotype, and phylogenetic characterization of the complete genome sequence of hepatitis B virus isolates from Malawian chronic carriers of the virus.
Fuminaka Sugauchi,Etsuro Orito,Hideaki Kato,Seiji Suzuki,Saori Kawakita,Yuko Sakamoto,Kouichi Fukushima,Toshio Akiba,Namiko Yoshihara,Ryuzo Ueda,Masashi Mizokami +10 more
TL;DR: Unique HBV isolates of subgroup A′ with ayw2 are prevalent in Malawi, and subgroup B′ with a relatively higher nucleotide diversity may be a HBV isolate characteristic of the indigenous population of some African countries.
Journal ArticleDOI
Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China.
TL;DR: Genotype C is the predominant genotype in Nanning, China, and genotype C maybe more associated with development of severe liver diseases than genotype B, which is commonly observed in cases with advanced liver diseases.
Journal ArticleDOI
Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma.
Masato Fujiyoshi,Atsushi Kuno,Masanori Gotoh,Moto Fukai,Hideki Yokoo,Hirofumi Kamachi,Toshiya Kamiyama,Masaaki Korenaga,Masashi Mizokami,Hisashi Narimatsu,Akinobu Taketomi +10 more
TL;DR: Serum WFA+-M2BP levels reflected both the pathological and functional progression of liver fibrosis comprehensively and continuously and were a significant risk factor for tumor recurrence and decreased overall survival after liver surgery independent of HCV infection.
Journal ArticleDOI
Difference in prognosis between patients infected with hepatitis B virus with genotype B and those with genotype C in the Okinawa Islands: a prospective study.
Tomokuni Nakayoshi,Tatsuji Maeshiro,Tomofumi Nakayoshi,Hiroki Nakasone,Hiroshi Sakugawa,Fukunori Kinjo,Etsuro Orito,Masashi Mizokami +7 more
TL;DR: HBV genotypes may influence the prognosis of HBV‐related chronic liver disease, and development of cirrhosis occurred less frequently in patients with genotype B compared with those with genotypes C, according to a comparative study undertaken in 72 patients with chronic hepatitis B confirmed clinically and pathologically.
Journal ArticleDOI
Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II).
Manami Inoue,Norie Kurahashi,Motoki Iwasaki,Yasuhito Tanaka,Masashi Mizokami,Mitsuhiko Noda,Shoichiro Tsugane +6 more
TL;DR: Although metabolic factors in the aggregate may be associated with an increased risk of HCC, the main contributors to this association under HCV infection appear to be overweight and high glucose.